339 related articles for article (PubMed ID: 29445149)
1. Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.
Xie Y; Zhang H; Guo XJ; Feng YC; He RZ; Li X; Yu S; Zhao Y; Shen M; Zhu F; Wang X; Wang M; Balakrishnan A; Ott M; Peng F; Qin RY
Cell Death Dis; 2018 Feb; 9(2):249. PubMed ID: 29445149
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
3. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
6. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
9. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract][Full Text] [Related]
10. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells.
Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL
Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
13. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Zhu B; Wei Y
Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
[TBL] [Abstract][Full Text] [Related]
15. JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.
Zhan M; Wen F; Liu L; Chen Z; Wei H; Zhou H
Tumour Biol; 2016 Aug; 37(8):11237-47. PubMed ID: 26945572
[TBL] [Abstract][Full Text] [Related]
16. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells.
Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J
Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
[TBL] [Abstract][Full Text] [Related]
20. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
Wang P; Lv L
Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]